FASTFX TAB

What this means for you

This application is over — abandoned 15 Feb 2016. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

86471455

Mark type

Stylized text

Filed

04 Dec 2014

Published for opposition

19 May 2015

Abandoned

15 Feb 2016

Attorney of record

Russell Blaymore

Goods and services

• Class 005 — Pharmaceuticals: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Sleeping pills/tablets; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient

Owner

• PLD ACQUISITIONS LLC, WESTBURY, NY, US
• PLD ACQUISITIONS LLC, WESTBURY, NY, US

Prosecution history

• 16 Feb 2016 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
• 15 Feb 2016 — ABANDONMENT - NO USE STATEMENT FILED
• 14 Jul 2015 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 19 May 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 19 May 2015 — PUBLISHED FOR OPPOSITION
• 29 Apr 2015 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 10 Apr 2015 — LAW OFFICE PUBLICATION REVIEW COMPLETED
• 10 Apr 2015 — ASSIGNED TO LIE
• 19 Mar 2015 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 19 Mar 2015 — EXAMINER'S AMENDMENT ENTERED
• 19 Mar 2015 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 19 Mar 2015 — EXAMINERS AMENDMENT E-MAILED
• 19 Mar 2015 — EXAMINERS AMENDMENT -WRITTEN
• 19 Mar 2015 — ASSIGNED TO EXAMINER
• 12 Dec 2014 — NOTICE OF PSEUDO MARK E-MAILED